n/a

Article Publish Status: FREE
Abstract Title:

Pasta Supplemented withExtract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study.

Abstract Source:

Metabolites. 2020 Oct 26 ;10(11). Epub 2020 Oct 26. PMID: 33114614

Abstract Author(s):

Rosaria Vincenza Giglio, Giuseppe Carruba, Arrigo F G Cicero, Maciej Banach, Angelo Maria Patti, Dragana Nikolic, Letizia Cocciadiferro, Maurizio Zarcone, Giuseppe Montalto, Anca Pantea Stoian, Yajnavalka Banerjee, Ali A Rizvi, Peter P Toth, Manfredi Rizzo

Article Affiliation:

Rosaria Vincenza Giglio

Abstract:

Food supplementation with(OFI) has been associated with a significant reduction in total cholesterol, body fat, hyperglycemia and blood pressure. Since OFI may also have antioxidant and anti-atherogenic properties, we hypothesized that its supplementation might reduce atherogenic lipoproteins, including small, dense low-density lipoproteins (sdLDL). Forty-nine patients (13 men and 36 women, mean age: 56± 5 years) with one or two criteria for the metabolic syndrome weekly consumed 500 g of pasta supplemented with 3% OFI extract (30% of insoluble polysaccharides with high antioxidant power) for 1 month. The full LDL subclass profile was assessed by gel electrophoresis (Lipoprint, Quantimetrix, Redondo Beach, CA, USA). After 1 month of pasta supplementation, waist circumference (= 0.0297), plasma glucose (<0.0001), triglycerides (= 0.0137), plasma creatinine (= 0.0244), urea and aspartate transaminase (<0.0001 for each) significantly decreased. A percentage increase in larger, less atherogenic LDL-1 (= 0.0002), with a concomitant reduction in smaller, denser LDL-2 (<0.0001) and LDL-3 (= 0.0004), were found. LDL-4 and-5 decreased, although not significantly. This is the first intervention study suggesting that pasta enriched with an OFI extract may have beneficial effects on some metabolic parameters and the LDL particle sizes, reducing atherogenic sdLDL. Future studies will help to establish if these findings impact cardiovascular outcomes.

Study Type : Human Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.